About the Authors
- Gitali Ganguli-Indra
-
* E-mail: indrag@onid.orst.edu (GGI); arup.indra@oregonstate.edu (AI)
Affiliation Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon, United States of America
- Christine Wasylyk
-
Affiliations IGBMC, Inserm U596 and CNRS UMR 7104, Illkirch, France, Université Louis Pasteur, Strasbourg, France
- Xiaobo Liang
-
Affiliation Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon, United States of America
- Regine Millon
-
Affiliation Centre Paul Strauss, Strasbourg, France
- Mark Leid
-
Affiliations Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon, United States of America, Environmental Health Sciences Center, Oregon State University, Corvallis, Oregon, United States of America
- Bohdan Wasylyk
-
Affiliations IGBMC, Inserm U596 and CNRS UMR 7104, Illkirch, France, Université Louis Pasteur, Strasbourg, France
- Joseph Abecassis
-
Affiliation Centre Paul Strauss, Strasbourg, France
- Arup Indra
-
* E-mail: indrag@onid.orst.edu (GGI); arup.indra@oregonstate.edu (AI)
Affiliations Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon, United States of America, Environmental Health Sciences Center, Oregon State University, Corvallis, Oregon, United States of America
Competing Interests
A provisional patent application has been filed related to CTIP2 expression pattern in human HNSCC.
Author Contributions
Conceived and designed the experiments: GI AKI. Performed the experiments: GI CW xL RM. Analyzed the data: GI JA AKI. Contributed reagents/materials/analysis tools: ML BW JA AKI. Wrote the paper: GI AKI. Intellectual advice during the course of the study: ML. Critically read the manuscript: BW.